Impact of integrated community-facility interventions model on neonatal mortality in rural Bangladesh- a quasi-experimental study
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0274836 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Tanvir M Huda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sydney School of Public Health, University of Sydney, Camperdown, Australia. Hauptthemen laut MEDLINE: Infant Mortality, Hospitals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Agency for International Development.
Abstract (Originalsprache)
Background
Neonatal mortality remains unacceptably high in many countries. WHO recommends that all newborns be assessed during the postnatal period and should seek prompt medical care if there is any danger sign. However, in many developing countries, only a small proportion of women receive postnatal care. Also, the quality of care in public health facilities is sub-optimal.
Methods
We designed an intervention package that included community health worker-assisted pregnancy and birth surveillance, post-natal visits to assess newborns on the first, third, seventh and twenty-eighth days of birth, referral for facility-based care, and establishing a newborn stabilization unit at the first level referral health facility. We did a quasi-experimental, propensity-score matched, controlled study in the Sylhet region of Bangladesh. We used a cross-sectional survey method at baseline and endline to measure the effect of our intervention. We considered two indicators for the primary outcome–(a) all-cause neonatal mortality rate and (b) case fatality of severe illness. Secondary outcomes were the proportion of neonates with signs and symptoms of severe illness who sought care in a hospital or a medically qualified provider.
Results
Our sample size was 9,940 live births (4,257 at baseline, 5,683 at end line) . Our intervention was significantly associated with a 39% reduction (aRR = 0.61, 95% CI: 0.40–0.93; p = 0.046) in the risk of neonatal mortality and 45% reduction (aRR = 0.55, 95% CI: 0.35–0.86; p = 0.001) in the risk of case fatality of severe illness among newborns in rural Bangladesh. The intervention significantly increased the care-seeking for severe illness at the first-level referral facility (DID 36.6%; 95% CI % 27.98 to 45.22; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Sydney School of Public Health, University of Sydney, Camperdown, Australia.
- International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
- Save the Children, Dhaka, Bangladesh.
- Carolina Population Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
- JSI Research and Training Institute Inc., Denver, Colorado, United States of America.
ORCID-Profile: Ishtiaq Mannan
Förderung
- United States Agency for International Development
Zitieren
APA
Huda, T. M., Chowdhury, S. K., Bhowmick, J., Priyanka, S. S., Shomik, M. S., Rahman, Q. S., Rahman, M., Mannan, I., & Arifeen, S. E. (2023). Impact of integrated community-facility interventions model on neonatal mortality in rural Bangladesh- a quasi-experimental study. PLOS ONE. https://doi.org/10.1371/journal.pone.0274836
Vancouver
Huda TM, Chowdhury SK, Bhowmick J, Priyanka SS, Shomik MS, Rahman QS, et al. Impact of integrated community-facility interventions model on neonatal mortality in rural Bangladesh- a quasi-experimental study. PLOS ONE. 2023. doi:10.1371/journal.pone.0274836
BibTeX
@article{Huda2023,
author = {Huda, Tanvir M and Chowdhury, Suman Kanti and Bhowmick, Jatan and Priyanka, Sabrina Sharmin and Shomik, Mohammad Sohel and Rahman, Qazi Sadeq-Ur and Rahman, Mizanur and Mannan, Ishtiaq and Arifeen, Shams El},
title = {Impact of integrated community-facility interventions model on neonatal mortality in rural Bangladesh- a quasi-experimental study},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0274836}
}
EUVIMED